1 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Active not recruiting 1, Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1 |
Follow Healthy Female Participants: new trials by email Literature Review of Healthy Female Participants trials Research Report on Healthy Female Participants
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants Navlimetostat, [14C]Navlimetostat - Healthy Female Participants | Phase 1 | Not yet recruiting | Bristol-Myers Squibb | 6 | 2026-09-16 | 2026-08-20 |
| A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal Subjects Estradiol/Levonorgestrel Transdermal System - Menopause, Healthy Female Participants | Phase 1 | Recruiting | Corium Innovations, Inc. | 250 | 2026-08-10 | 2026-09-10 |
| A Study to Assess the Bioavailability and Adhesion of Estradiol/Levonorgestrel TDS in Healthy Post-Menopausal Female Participants Test Estradiol/Levonorgestrel Transdermal Delivery System, Climara Pro® (Estradiol/Levonorgestrel Transdermal System) - Healthy Female Participants, Postmenopause | Phase 1 | Active not recruiting | Corium Innovations, Inc. | 68 | 2026-07-01 | 2026-10-01 |
| Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential. Zibotentan, EE/LNG - Healthy Female Participants | Phase 1 | Completed | AstraZeneca | 24 | 2022-08-24 | 2023-02-09 |
| A Study to Test the Interaction of Padsevonil With Oral Contraceptives in Healthy Female Participants Padsevonil, Microgynon 30® - Healthy Female Participants | Phase 1 | Terminated | UCB Biopharma SRL | 14 | 2019-10-23 | 2021-06-24 |
Renal Insufficiency, Chronic (1)
Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Estradiol (2) · ZD4054 (1) · padsevonil (1)
Corium Innovations, Inc. (2) · AstraZeneca (1) · Bristol-Myers Squibb (1) · UCB Biopharma SRL (1)
United States (3) · India (2) · Netherlands (1) · United Kingdom (1)
Niraj Vasisht (1)
2019 (1)